US 10836772
DNA polymerase IIIC inhibitors and use thereof
granted A61KA61K31/519A61P
Quick answer
US patent 10836772 (DNA polymerase IIIC inhibitors and use thereof) held by Acurx Pharmaceuticals, Inc. expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Acurx Pharmaceuticals, Inc.
- Grant date
- Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/519, A61P, A61P31/04